Odd, wonder why Gerald would now want an easy way to begin producing MANF in large scale quantities quickly at at a cost effective way?
"Dyadic to assist in the evaluation of the potential of Dyadic’s proprietary C1 biologics production platform to manufacture MANF for clinical and commercial use."
Aloha
(3)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links